Security Snapshot

Gabelli Healthcare & WellnessRx Trust - Common Shares, $0.001 par value (GRX) Institutional Ownership

CUSIP: 36246K103

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2026

13F reference period

Q2 2026

Institutions Reporting

51

Shares (Excl. Options)

5.88MFull value: 5,882,526 · shares · 30 Jun 2026

Price

$9.45

The headline uses the Q2 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended. Newer periods in the history table contain incoming reports and may be incomplete.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Create free account and return here Sign in and return here Review latest holder period
Security type / class
Equity / Common Shares, $0.001 par value
Symbol
GRX on NYSE
All holders as of 30 Jun 2026
Q2 2026
Total 13F shares
5,882,526
Latest holder snapshot 5 signals
Total 13F value
$55,591,005
Portfolio coverage rank
0%
Share change
-61,766
Value change
-$556,551
Number of holders
51
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
15,049,811
SEC-reported price per share
$9.51
Insider filing price
$9.51
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • GRX - Gabelli Healthcare & WellnessRx Trust - Common Shares, $0.001 par value is tracked under CUSIP 36246K103.
  • 51 institutions reported positions in Q2 2026.
  • 2 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 51 to 51 between Q1 2026 and Q2 2026.
  • SEC-reported value moved from
    $53.81MFull value: $53,805,869 · USD · 31 Mar 2026
    to
    $55.59MFull value: $55,591,005 · USD · 30 Jun 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 51 institutions filings for Q2 2026.

Open SEC evidence

Security key

36246K103

13F reference period

Q2 2026

13F holders

51

13D/G owners

2

CIK / CUSIP context first

Open Q2 2026 holders GRX full holder history Gabelli Healthcare & WellnessRx Trust SEC filings Gabelli Healthcare & WellnessRx Trust insider transactions

Broader feeds

Latest 13F filings Latest 13D/G filings All securities

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
2
Security
GRX
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Saba Capital Management, L.P. 14% +7.8% $20,409,110 +$952,474 2,155,133 +4.9% Saba Capital Management, L.P. 27 Aug 2026
SIT INVESTMENT ASSOCIATES INC 5.4% $7,912,344 833,756 Sit Investment Associates, Inc. 30 Sep 2025
As of 30 Jun 2026, 51 institutional investors reported holding
5.88MFull value: 5,882,526 · shares · 30 Jun 2026
shares of Gabelli Healthcare & WellnessRx Trust - Common Shares, $0.001 par value (GRX). This represents 39% of the company’s total
15.05MFull value: 15,049,811 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
39%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Saba Capital Management, L.P. 14% 2,118,201 0% 0.61% $20,016,999
SIT INVESTMENT ASSOCIATES INC 8% 1,198,562 0% 0.21% $11,326,000
GAMCO INVESTORS, INC. ET AL 2.3% 346,026 0% 0.03% $3,269,944
BLUE BELL PRIVATE WEALTH MANAGEMENT, LLC 2.2% 327,658 +6.1% 0.39% $3,096,363
LPL Financial LLC 1.7% 259,281 -6.8% 0% $2,450,209
WELLS FARGO & COMPANY/MN 1.7% 253,218 -2.1% 0% $2,392,912
MORGAN STANLEY 1.5% 228,713 +8.5% 0% $2,161,341
EVOLVE PRIVATE WEALTH, LLC 1.2% 176,625 -1.1% 0.1% $1,669,106
Aviance Capital Partners, LLC 1.1% 171,442 +0.07% 0.17% $1,620,130
STEPHENS INC /AR/ 0.79% 118,349 -1.9% 0.01% $1,118,398
CAPSTONE INVESTMENT ADVISORS, LLC 0.66% 99,441 0% 0.01% $939,717
&PARTNERS 0.62% 93,507 -11% 0% $881,871
UHLMANN PRICE SECURITIES, LLC 0.52% 77,700 +26% 0.03% $734,314
NewEdge Advisors, LLC 0.44% 66,589 -1.1% 0% $629,268
Atlas Wealth LLC 0.41% 61,294 0.08% $579,228
Creative Planning 0.18% 27,005 -0.52% 0% $255,195
Janney Montgomery Scott LLC 0.18% 26,872 -6% 0% $254,000
Beacon Pointe Advisors, LLC 0.16% 24,055 -26% 0% $227,320
Alessandra Capital Management, LLC 0.15% 23,087 -22% 0.15% $218,172
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC 0.15% 22,186 -2.2% 0% $212,987
Waverly Advisors, LLC 0.13% 20,290 -27% 0% $191,739
UBS Group AG 0.13% 19,116 -67% 0% $180,646
COMMONWEALTH EQUITY SERVICES, LLC 0.1% 14,563 +0.01% 0% $137,620
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.09% 13,947 -25% 0% $131,799
CITADEL ADVISORS LLC 0.09% 13,897 0% $131,327

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
51
Headline period
Q2 2026
Rows shown
1-25 of 51
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 987,124 $9,388,627 +$554,166 $9.51 17
2026 Q2 5,882,526 $55,591,005 -$556,551 $9.45 51
2026 Q1 5,945,142 $53,805,869 +$93,528 $9.05 51
2025 Q4 5,930,184 $57,107,661 +$937,653 $9.63 53
2025 Q3 5,647,549 $51,236,923 +$1,958,322 $9.07 54
2025 Q2 5,429,514 $51,318,980 +$1,090,583 $9.45 58
2025 Q1 5,185,556 $52,270,856 +$718,989 $10.08 61
2024 Q4 5,270,301 $50,912,869 +$3,900,325 $9.64 67
2024 Q3 4,857,274 $53,072,330 +$3,192,330 $10.95 66
2024 Q2 4,590,471 $43,930,948 +$790,501 $9.58 67
2024 Q1 4,363,392 $44,668,783 +$1,228,402 $10.24 68
2023 Q4 4,287,218 $39,995,577 +$1,936,192 $9.33 71
2023 Q3 4,092,087 $35,099,311 +$881,876 $8.58 71
2023 Q2 3,989,120 $39,717,899 -$844,353 $9.96 71
2023 Q1 4,070,996 $41,067,738 +$665,564 $10.09 69
2022 Q4 4,166,306 $42,829,596 +$1,398,554 $10.28 67
2022 Q3 3,953,651 $37,573,339 -$1,545,108 $9.50 55
2022 Q2 4,110,603 $44,065,987 +$1,682,020 $10.72 58
2022 Q1 3,952,914 $50,670,179 -$3,968,218 $12.82 53
2021 Q4 4,132,189 $56,069,916 -$5,307,668 $13.57 53
2021 Q3 4,560,120 $60,237,215 -$4,106,549 $13.21 50
2021 Q2 4,917,592 $66,379,242 -$3,990,032 $13.50 57
2021 Q1 5,215,180 $64,977,146 -$866,262 $12.46 59
2020 Q4 5,288,796 $63,192,100 +$852,113 $11.95 58
2020 Q3 5,197,261 $53,601,949 -$1,789,951 $10.32 57
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .